Chiauranib Uses, Dosage, Side Effects and more
Chiauranib is under investigation in clinical trial NCT03974243 (Chiauranib in Combination With Chidamide in Patients With Relapsed/refractory Non-hodgkin's Lymphoma).
| Attribute | Details |
|---|---|
| Trade Name | Chiauranib |
| Generic | Chiauranib |
| Type | |
| Formula | C27H21N3O3 |
| Weight | Average: 435.483 Monoisotopic: 435.158291548 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
